Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19

J Addict Med. 2021 Sep-Oct;15(5):439-440. doi: 10.1097/ADM.0000000000000786.

A Taylor Kelley^{1

2

3

4}, Matthew T Dungan^{5

2

3}, Adam J Gordon^{1

2

3

6

3}

¹ Vulnerable Veteran Innovative PACT (VIP) Initiative Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation, VA Salt Lake City Health Care System, Salt Lake City, UT.
² Program for Addiction Research Clinical Care, Knowledge and Advocacy (PARCKA), University of Utah School of Medicine.
³ Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT.
⁴ Department of Internal Medicine, Division of General Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT.
⁵ Vulnerable Veteran Innovative PACT (VIP) Initiative Informatics Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation VA Salt Lake City Health Care System Salt Lake City, UT.
⁶ Greater Intermountain Node (GIN) of the NIDA Clinical Trials Network, University of Utah School of Medicine.

No abstract available

Publication types